Pars Planitis Market Trends Analysis, Growth Opportunities and Challenges, Clinical Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast
Pars Planitis, is an eye condition in which the narrow space (pars plana) between the colored region of the eye (iris) and the choroid becomes inflamed. Eyesight blurriness, dark spots in the vision, and progressive vision loss may result from this. Cataracts, retinal detachment, or macular edoema (fluid within the retina) may appear as the illness worsens. Pars planitis most frequently affects young males and is idiopathic, meaning it has no known cause or symptoms. It can, however, be linked to other autoimmune diseases, including multiple sclerosis and sarcoidosis.
Even though pars planitis cannot be cured, it is treated. Surgery or the use of oral or injectable medications to slow the course of the disease may be included in sight-preserving therapy.
DelveInsight’s “Pars Planitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Pars Planitis, historical and forecasted epidemiology as well as the Pars Planitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Pars Planitis Market Report:
The Gender-wise prevalence of Pars planitis is equal in numbers for both male and female
Pars planitis can affect the eye almost at any age but begins between the ages of 30 and 40
According to the reports, the prevalence of Pars Planitis was estimated to be 24 cases out of 100,000 people in 2021
As per the studies, 20% of the patients affected by Pars planitis can suffer visual loss when the disease is left untreated
Request a sample for the Pars Planitis Report
The symptoms of Pars Planitis include –
Blurred vision
Redness in the eyeball
Dark floating spots that intrude the clarity of eyesight
Swelling inside the eye
Epidemiology Segmentation of Pars Planitis:
Prevalent Cases of Pars Planitis in the 7MM [2019-2032]
Age-Specific Cases of Pars Planitis in the 7MM [2019–2032]
Gender-Specific Cases of Pars Planitis in the 7MM [2019–2032]
Diagnosed and Treated Cases of Pars Planitis in the 7MM [2019–2032]
Pars Planitis Market
The dynamics of the Pars Planitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Myfortic, LFG316, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @ Pars Planitis Market Landscape
Pars Planitis Pipeline Therapies:
Dexamethasone
Myfortic
LFG316
triamcinolone acetonide
Sirolimus
Pars Planitis Pipeline Key Companies:
Allergan
Novartis Pharmaceuticals
EyePoint Pharmaceuticals
Clearside Biomedical
Click here to read more about Pars Planitis Market Outlook 2032
Related Reports:
Pars Planitis Epidemiology
DelveInsight's 'Pars Planitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Pars Planitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diagnostic Imaging Equipment Market
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
"DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Sialidosis Market
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027
Latest Reports by DelveInsight
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
To know more about our Competitive Services, Click here: Pharma Competitive Intelligence
Comments
Post a Comment